DME and HME suppliers
Financing for DME and HME suppliers
Direct answer
Practition Finance explains capital options for DME and HME suppliers, across 3 structures: equipment financing, medical receivables factoring, and working capital, and connects suppliers to funding sources that account for accreditation, the surety bond requirement, and competitive bidding. Program availability varies by state, and every figure here carries its source and date.
As of October 2026
A durable and home medical equipment supplier carries two kinds of capital pressure at once: the inventory and rental fleet it has to hold before a single unit generates revenue, and the reimbursement lag on Medicare Part B and commercial claims once that unit is delivered. Both pressures are structural to the business model rather than symptoms of poor management, and both recur every time the supplier adds a product line or a resupply program.
Three capital events dominate the sector: financing inventory and a rental fleet, financing receivables against Part B and commercial claims once units are in the field, and acquiring an existing supplier where accreditation and existing payer contracts carry much of the value. A supplier evaluating any one of these has to account for the accreditation and bonding requirements that sit ahead of the financing question.
A lender reads accreditation and surety bond status first, then the split between rental and sale revenue, then denial rate and documentation quality, and finally payer mix, because a supplier that cannot demonstrate accreditation or bonding cannot hold a competitive bidding contract regardless of how strong its receivable base looks otherwise.
The 3 capital events you will face
Inventory and rental fleet
A DME supplier has to hold inventory, wheelchairs, hospital beds, CPAP and oxygen equipment, ahead of any order, and a capped rental fleet in particular ties up capital for the entire rental period rather than converting to revenue at time of sale. CGMs and insulin pumps moving toward monthly rental under the CMS competitive bidding round finalized in late 2025 add another category of equipment a supplier has to finance before it earns anything back. Equipment financing structured against this inventory and fleet, rather than general working capital, is the program most suppliers reach for first because it matches the financing term to the equipment's own useful life.
Receivable financing against Part B and commercial claims
Once equipment is delivered, the supplier is owed against Medicare Part B, Medicaid, and commercial payer claims, and that reimbursement moves on the same delayed cycle as any other insurance-billed service. Denial rates in this category run higher than average when documentation of medical necessity is incomplete, and a supplier growing its resupply program in particular can see its receivable base outpace its cash position quickly. Medical receivables factoring, structured for Medicare's anti-assignment rule the same way it is in other insurance-billed fields, converts the finalized portion of that receivable into cash without waiting for the full remittance cycle.
Acquisition of an existing supplier
Buying an existing DME or HME supplier is largely a purchase of its accreditation status, its existing bid area contracts, and its established resupply relationships, since a new entrant has to complete accreditation and post the required surety bond before it can compete for a bid area at all. A lender underwriting the acquisition looks at the seller's rental versus sale revenue split and its denial rate history as evidence the business can sustain its reimbursement stream after the ownership change, and typically layers working capital on top of the purchase price for the buyer's own receivable gap.
Programs ranked for your situation
The ranking below moves from the equipment-side financing every supplier needs to hold inventory, through the receivable financing that follows delivery, to the acquisition financing that buys an accredited operation outright
- 01Equipment financing and leasing
Term financing matched to the useful life of inventory and rental fleet equipment, the first capital need for most suppliers before any claim is ever billed
- 02Medical receivables factoring
Converts finalized Part B and commercial claims into cash ahead of the full remittance cycle, structured through a lockbox arrangement where Medicare's anti-assignment rule applies
- 03Working capital term loan
General-purpose funding for resupply program growth, bid area entry costs, and gaps that are not tied to a specific equipment purchase
- 04Practice acquisition
Term financing for buying an accredited supplier with existing bid area contracts, commonly paired with a working capital layer for the buyer's post-closing receivable gap
What a funder reads on your file first
A DME file is read for its accreditation and bonding status before anything else, since neither can be financed away, followed by its revenue mix and receivable discipline
| What is read | Market reference | Confidence | How it is read |
|---|---|---|---|
| Bid surety bond status | $50,000 per bid area | VerifiedAugust 2026 | Whether the supplier has posted the required bond per bid area, a prerequisite for holding a competitive bidding contract at all. |
| Denial rate | Under 5% top quartile, 8% to 10% average | VerifiedAugust 2026 | How often claims are rejected for incomplete medical necessity documentation, a common failure point in this category. |
| Clean claim rate | 95% and above good, 98% and above excellent | VerifiedAugust 2026 | The share of claims accepted on first submission, read as a proxy for documentation and coding discipline. |
| Days in accounts receivable | Under 30 high performing, 30 to 40 acceptable, over 50 a problem | VerifiedAugust 2026 | How far the collection cycle runs past the acceptable band, factored into how a factor prices an advance. |
| Factoring advance rate | 70% to 95% of net collectible value | VerifiedAugust 2026 | The share of net collectible value a factor will advance, which depends on payer mix and documentation quality. |
Accreditation, the surety bond, and competitive bidding
Competitive bidding and the surety bond requirement set who can hold the contract before any funder looks at the receivable. A supplier needs DMEPOS accreditation and has to post a $50,000 surety bond per bid area to participate in a Medicare competitive bidding round, and neither requirement is something a lender or factor can substitute for with additional collateral or a stronger credit file.
The CMS competitive bidding round finalized in late 2025 moves CGMs and insulin pumps to a monthly capped rental model, which changes the revenue timing for suppliers carrying those product lines and shifts more of the business toward the rental-fleet financing structure rather than a straightforward equipment sale.
Once accreditation and bonding are in place, the receivable itself still runs into Medicare's anti-assignment rule on the Part B side. A factor financing a DME supplier's Medicare claims uses the same double lockbox and daily sweep structure used across insurance-billed receivables: a lockbox in the supplier's own name receives the government remittance, and funds sweep into the funder's account afterward, while commercial payer remittances can carry a direct notice of assignment.
Key facts
These figures cover the accreditation, bonding, and revenue-cycle benchmarks a lender or factor applies to a DME and HME file
- DME bid surety bond: $50,000 per bid area5VerifiedAugust 2026
- Denial rate benchmark: Under 5% top quartile, 8% to 10% average6VerifiedAugust 2026
- Clean claim rate benchmark: 95% and above good, 98% and above excellent7VerifiedAugust 2026
- Days in AR benchmark: Under 30 high performing, 30 to 40 acceptable, over 50 a problem8VerifiedAugust 2026
- Factoring advance rate: 70% to 95% of net collectible value9VerifiedAugust 2026
These are figures the market publishes, current as of the date beside each one. None of it is a quote, an offer, or an indication of terms.
Your options, program by program
- Medical receivables factoring for DME and HME suppliers
How medical receivables factoring advances cash against a DME or HME supplier's Part B and commercial claims while bonding rules stay separate
Other fields in the same language
Operators read on the same numbers, each with its own capital events and document set
What owners in this field ask
01What has to be in place before a DME supplier can even seek financing?
DMEPOS accreditation and the $50,000 per bid area surety bond both have to be in place before a supplier can hold a competitive bidding contract, and neither can be substituted with a stronger credit file or additional collateral. A lender confirms both before evaluating the equipment or receivable financing request itself.
02Why does the rental versus sale revenue split matter to a lender?
Rental revenue, particularly capped rental for equipment like CGMs and insulin pumps under the newer competitive bidding rules, ties up capital across the rental period before it converts to cash the way an outright sale would. A lender reads a supplier's mix between the two to judge how much ongoing equipment financing the business will continue to need.
03Can a DME supplier factor its Medicare claims directly?
Medicare claims cannot be assigned directly to a factor because of the anti-assignment rule in the Social Security Act. The compliant structure is a double lockbox with a daily sweep, where the supplier keeps its own government-facing lockbox and funds sweep into the funder's account after remittance, while commercial claims can carry a direct notice of assignment.
04What does a lender look at when financing an acquisition of a DME supplier?
A lender reads the seller's accreditation and bonding status first, since those cannot transfer automatically, then the rental versus sale revenue split and denial rate history as evidence the receivable stream will hold up after the ownership change. Working capital is commonly layered onto the acquisition financing for the buyer's own post-closing receivable gap.
05How did the 2025 competitive bidding round change DME financing needs?
The round finalized in late 2025 moves CGMs and insulin pumps to a monthly capped rental model, which shifts more supplier revenue toward the rental-fleet financing structure and away from an outright equipment sale. Suppliers carrying those product lines need equipment financing sized to a longer revenue-recognition timeline as a result.
06Why does denial rate run higher in DME than in other insurance-billed fields?
Denials in this category are often tied to incomplete documentation of medical necessity for the specific equipment billed, a requirement more granular than in many other insurance-billed categories. A factor or lender reads a supplier's denial rate as a direct measure of documentation discipline before pricing an advance.
Sources
- 1CMS: DMEPOS competitive bidding program
- 2GAO: DMEPOS bidding oversight
- 3SBA lending programs
- 4MGMA benchmark data
- 5GAO
- 6MGMA-cited
- 7Revenue Synergy
- 8MGMA and HFMA aligned sources
- 9Clarify Capital, Crestmont, Factor Finders
Take the checklist with you
Healthcare businesses
Healthcare Cash Flow Kit
The gap between service date and remittance, and what closes it
PDF · 9 pages · v1.0
- The healthcare business document checklist, in the order a funder asks for it
- The factoring readiness checklist
- The double lockbox explained, with the government-payer rule
- The payroll gap worksheet
- Net collectible value versus gross charges, worked through
- The revenue-cycle benchmarks a funder checks first
Run a Fit Check to see which financing fits a DME or HME supplier's accreditation status and revenue mix
See which programs fit you
The Fit Check is educational. It names the program categories commonly used in situations like the one described, and it recommends nothing.